Literature DB >> 9574712

Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila.

F Higa1, N Kusano, M Tateyama, T Shinzato, N Arakaki, K Kawakami, A Saito.   

Abstract

We developed a new simple assay for the quantitation of the activities of drugs against intracellular Legionella pneumophila. The cells of a murine macrophage-like cell line (J774.1 cells) allowed the intracellular growth and replication of the bacteria, which ultimately resulted in cell death. The infected J774.1 cell monolayers in 96-well microplates were first treated with antibiotics and were further cultured for 72 h. The number of viable J774.1 cells in each well was quantified by a colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and an enzyme-linked immunosorbent assay reader. The number of growing bacteria in each well was also determined by counting the numbers of CFU on buffered charcoal yeast extract-alpha agar plates. Viable J774.1 cell counts, determined by the colorimetric assay, were inversely proportional to the number of intracellular replicating bacteria. The minimum extracellular concentrations (MIECs) of 24 antibiotics causing inhibition of intracellular growth of L. pneumophila were determined by the colorimetric assay system. The MIECs of beta-lactams and aminoglycosides were markedly higher than the MICs in buffered yeast extract-alpha broth. The MIECs of macrolides, fluoroquinolones, rifampin, and minocycline were similar to the respective MICs. According to their intracellular activities, clarithromycin and sparfloxacin were the most potent among the macrolides or fluoroquinolones tested in this study. Our results indicated that the MTT assay system allows comparative and quantitative evaluations of the intracellular activities of antibiotics and efficient processing of a large number of samples.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574712      PMCID: PMC104835          DOI: 10.1128/JCM.36.5.1392-1398.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  A one-plate assay for macrophage bactericidal activity.

Authors:  R Peck
Journal:  J Immunol Methods       Date:  1985-09-03       Impact factor: 2.303

2.  Antibiotic susceptibility of Legionella pneumophia Philadelphia-1 in cultured guinea-pig peritoneal macrophages.

Authors:  S Yoshida; Y Mizuguchi
Journal:  J Gen Microbiol       Date:  1984-04

3.  Identification of a cytotoxin produced by Legionella pneumophila.

Authors:  R L Friedman; B H Iglewski; R D Miller
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

4.  Evidence for apoptosis of human macrophage-like HL-60 cells by Legionella pneumophila infection.

Authors:  A Müller; J Hacker; B C Brand
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

6.  Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.

Authors:  J L Vildé; E Dournon; P Rajagopalan
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

8.  Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.

Authors:  D Havlichek; L Saravolatz; D Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

9.  Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.

Authors:  P H Edelstein; K Calarco; V K Yasui
Journal:  Am Rev Respir Dis       Date:  1984-11

10.  In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.

Authors:  P B Fernandes; R Bailer; R Swanson; C W Hanson; E McDonald; N Ramer; D Hardy; N Shipkowitz; R R Bower; E Gade
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

View more
  4 in total

1.  Incomplete activation of macrophage apoptosis during intracellular replication of Legionella pneumophila.

Authors:  Alaeddin Abu-Zant; Marina Santic; Maelle Molmeret; Snake Jones; Jürgen Helbig; Yousef Abu Kwaik
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates.

Authors:  Jacques Dubois; Maïtée Dubois; Jean-François Martel; Kelly Aubart; Deborah Butler
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Immunomodulatory potential of nanocurcumin-based formulation.

Authors:  Mahendra Kumar Trivedi; Sambhu Charan Mondal; Mayank Gangwar; Snehasis Jana
Journal:  Inflammopharmacology       Date:  2017-09-18       Impact factor: 4.473

4.  In Vitro and Intracellular Activities of Omadacycline against Legionella pneumophila.

Authors:  Jacques Dubois; Maïtée Dubois; Jean-François Martel
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.